|
|
|
|
Click on a highlighted title to read the PDF.
| APTIMA®
for Chlamydia trachomatis and Neisseria gonorrhoeae - Posters |
| Title |
Primary
Author and Affiliation |
Poster
- Where & When Presented |
| Four and a Half Year History of APTIMA® GC/CT Nucleic Acid Amplification Testing (NAAT) in Children Seen for Sexual Abuse |
Chapin; Rhode Island Hospital, Hasbro Children’s Hospital |
Poster 2010 CDC STD Prevention Conference |
| Sentinel Surveillance for Rectal Chlamydia and Gonorrhea in
San Francisco |
Bernstein; San Francisco Dept. of Public Health |
Poster 2009 ISSTDR |
| Stability of Seeded Swab Specimens for the Detection of Chlamydia trachomatis in the Gen-Probe APTIMA Test |
Schachter; University of California, San Francisco |
Poster 2009 ISSTDR |
| Chlamydia and Gonorrhea Infections at the Time of a Positive RPR in STD Clinic Patients |
Philip; San Francisco Department of Public Health |
Poster 2009 ISSTDR |
| Performance of Nucleic
Acid Amplification Tests (NAATs) for Chlamydia and Gonococcal
Infections of the Oropharynx and Rectum |
Klausner; San Francisco
DOH, San Francisco, CA |
Poster
2004 American Society of Microbiology Meeting |
| Evaluation of the
APTIMA CT Assay as a Direct and Confirmatory Method for the Detection
of Chlamydia trachomatis |
LeBar; Hospital
Consolidated Services, Southfield, MI |
Poster
2004 Clinical Virology Meeting |
| Use of M4 Transport
Medium for Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) with the APTIMA Combo 2, APTIMA
CT and APTIMA GC Assays |
LeBar;
Hospital Consolidated Services, Southfield, MI |
Poster
2004 American Society of Microbiology Meeting |
| Use of the APTIMA Combo 2 Test
for Chlamydia trachomatis and Neisseria gonorrhoeae in Pharyngeal and Rectal Specimens |
Ferrero;
San Joaquin PH, Stockton, CA |
Poster
2003 American Society of Microbiology Meeting |
| Simultaneous Detection of Chlamydia
trachomatis and Neisseria gonorrhoeae in the APTIMA
Combo 2 Assay by Testing Cervical Swabs Previously tested by LCx
or ProbeTec Assays |
Chernesky; St. Joseph's Hospital,
Hamilton, Canada |
Poster
2002 European Congress of Clinical Microbiology and Infectious
Disease |
| APTIMA®
General Purpose Reagents (GPR) - Posters |
| Title |
Primary Author and Affiliation |
Poster
- Where & When Presented |
Semi-Automated and
Fully Automated Viral Transcription-Medicated Amplification Nucleic
Acid Test Assay Development Using General Purpose Reagents
|
Getman; Gen-Probe
Incorporated, San Diego, CA
|
Poster
2004 Clinical Virology Meeting |
| APTIMA®
Analyte Specific Reagents (ASR) for Trichomonas vaginalis - Posters |
| Title |
Primary
Author and Affiliation |
Poster
- Where & When Presented |
| Comparison of Transcription-Mediated Amplification (TMA) and Polymerase Chain Reaction (PCR) Methods for Detection of Trichomonas vaginalis from SUN Study Patients |
Chapin; Rhode Island Hospital, The Miriam Hospital |
Poster 2010 CDC STD Prevention Conference |
| Detection of Trichomonas vaginalis (TV) in a Varied Patient Population Using APTIMA Trichomonas Analyte Specific Reagents (ASRS) |
Chapin; Rhode Island Hospital, The Miriam Hospital |
Poster 2009 ISSTDR |
| Analytical Performance of the APTIMA® Trichomonas Assay on the Automated TIGRIS® DTS® System |
Getman; Gen-Probe Incorporated, San Diego, CA |
Poster 2009 ISSTDR |
| Analytical Sensitivity of the Urine-Based APTIMA® Trichomonas vaginalis Molecular Assay Using the Automated TIGRIS® Platform |
Freeman; San Francisco Department of Public Health |
Poster 2009 ISSTDR |
| Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in Young Women in Kenya Using the Gen-Probe APTIMA™ Assays |
Moncada; University of California, San Francisco, Kenya Medical Research Institute |
Poster 2009 ISSTDR |
| Endocervical and Vaginal Specimens are Comparable for Detection of
T. vaginalis Using Transcription-Mediated Amplification (TMA) |
Hobbs; University of North Carolina |
Poster 2009 ISSTDR |
| Clearance of Chlamydial Ribosomal RNA by APTIMA Combo 2® Testing in Women With Chlamydia Treated with Azithromycin |
Renault; Stanford University School of Medicine, Palo Alto, CA |
Poster 2009 ISSTDR |
| Evaluation of the Papanicolaou Stain Versus APTIMA® Trichomonas vaginalis Analyte Specific Reagents for the Detection of Trichomonas vaginalis from Cytyc® ThinPrep Vials |
Fuller; Wishard Health Services Indiana University, IN |
Poster
2007 American Society of Microbiology Meeting |
| Evaluation of Real-Time PCR
and Transcription-Mediated Amplification for Detection of Trichomonas
vaginalis in Urine |
Hobbs; The University of North
Carolina at Chapel Hill, Chapel Hill, NC |
Poster
2006 American Society of Microbiology Meeting |
| Use of Gen-Probe APTIMA®
Tests to Detect Multiple Etiologies of Urethritis and Cervicitis
in Sexually Transmitted Disease (STD) Clinics |
Gaydos; The Johns Hopkins University,
Baltimore, MD |
Poster
2006 American Society of Microbiology Meeting |
| Comparison of Cervical
Samples to vaginal Samples for the Detection of Trichomonas
vaginalis Using a GEN-PROBE Research Assay for rRNA |
Gaydos; The Johns
Hopkins University, Baltimore, MD |
Poster
2005 American Society of Microbiology Meeting |
| Comparison between
the research GEN-PROBE APTIMA formatted assay for rRNA (AMP-TV)
and a real-time PCR, B-TUB FRET, for the detection of Trichomonas
vaginalis |
Gaydos; The Johns
Hopkins University, Baltimore, MD |
Poster
2005 American Society of Microbiology Meeting |
| Comparison of Transcription-Mediated
Amplification, culture and PCR methods for detection of Trichomonas
vaginalis |
Getman; Gen-Probe Incorporated,
San Diego, CA |
Poster
2005 Scheveningen Molecular Meeting |
| Detection of Trichomonas
vaginalis (TV) in Female Urine and Vaginal Specimens Using
a Transcription-Mediated Amplification (TMA) Assay |
Martin; LSU Health
Sciences Center and the Gulf South STI TM Cooperative Research
Center, New Orleans, LA |
Poster
2005 International Society for Sexually Transmitted Diseases Research |
| Rapid Detection of Trichomonas
vaginalis from Vaginal Specimens by Transcription-Mediated
Amplification |
Sitay; Gen-Probe Incorporated,
San Diego, CA |
Poster
2003 American Society of Microbiology Meeting |
| APTIMA® HPV |
| Title |
Primary
Author and Affiliation |
Poster
- Where & When Presented |
| Clinical Performance of the APTIMA HPV Assay for Dectection of E6/E7 mRNA from High-Risk HPV Types in Liquid Based Cytology Specimens |
Hill; Gen-Probe Incorporated, San Diego, CA |
Poster 2009 ISSTDR |
| Clinical Correlation of APTIMA® HPV Assay in Comparison with Hybrid Capture 2® Test in Cervical Cancer Screening |
Ratnam; Public Health Laboratory, Canada |
Poster 2009 ISSTDR |
| Analytical Performance of the APTIMA HPV Assay on the PANTHER Analyzer |
Worlock; Gen-Probe Incorporated, San Diego, CA |
Poster 2009 ISSTDR |
| Performance of APTIMA HPV Assay in Referral Population |
Getman; Gen-Probe Incorporate, San Diego, California |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Evaluation of the APTIMA Cervical Specimen Collection and Transport Kit |
Nugent; Gen-Probe Incorporate, San Diego, California |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Comparison of Three High-Risk HPV (HR-HPV) Tests on ASC Samples with Follow-up |
Schledemann: Odense University Hospital, Denmark |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Performance of HPV E6/E7 mRNA and DNA Tests for the Detection of CIN or Worse: Results from a Multicentre Canadian Study |
Ratnam; Public Health Laboratory, St. John's, Canada |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Results of the French APTIMA HPV Screening Evaluation (FASE Study) |
Monsonego; European Institute of the Cervix, Paris |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Detection of HPV mRNA in Cytology Specimens with the APTIMA HPV HPV Assay |
Clad; Universitaets-Frauenklinik, Freiburg, Germany |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Does RNA Testing Detect Clinically Significant HPV Infection? |
Cuschieri; Royal Infirmary of Edinburgh |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| HPV mRNA and p16INK4a as Triage Markers in Cervical Cytology |
Reuschenbach; University of Heidelberg, Heidelberg, Germany |
Abstract 2009, 25th International Papillomavirus Conference and Clinical Workshop (IPV) |
| Characterization
of a Prototype Transcription-Mediated Amplification (TMA) Based
Diagnostic Assay for Detection of HPV E6/E7 mRNA in LBC Media |
Kolk; Gen-Probe
Incorporated, San Diego, CA |
Poster
2006 EUROGIN, Paris, France |
| PCA3 |
| Title |
Primary
Author and Affiliation |
Publication |
| Clinical Use of Urine PCA3 mRNA Testing. |
Shappell, S and Marks, L. |
Urology Times. 2009. 37(10):40-42. |
| Urinary Prostate Cancer 3 Test: Toward the Age of Reason? |
Vlaeminck-Guillem, V et al.; Centre Hospitalier Lyon Sud, Pierre-Benite, France |
J.Urol. 2009. 8 July. In Press. |
| Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram. |
Chun, F, et al.; University Hospital Hamburg-Eppendorf, Hamburg, Germany |
European Urology. 2009 October; 56(4):583-752. |
| Prostate Cancer in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3). |
Kirby, RS, Fitzpatrick, JM, Irani, J, The Prostate Centre, London, UK |
BJU Intl. 2009. Accepted for publication 2.09.
|
| Rational Approach to Implementation of Prostate Cancer Antigen 3 into Clinical Care. |
Wang, R, et al.; University of Michigan, Ann Arbor, Michigan |
Cancer. 2009 Sep 1;115(17):3879-86. |
| New and Novel Markers for rostate Cancer Detection. |
Risk, M, Lin, D.; University of Washington Medical Center, Seattle, WA |
Current Urology Reports. 2009, 10:179-186. |
| New Markers and Multivariate Models for Prostate Cancer Detection. |
Stephan, C et al.; Universitätsmedizin Berlin, Berlin, Germany |
AntiCancer Research. 2009;29:2589-2600. |
| The Use of PCA3 in the Diagnosis of Prostate Cancer. |
Hessels, D, Schalken, J; University Hospital Nijmegen, The Netherlands |
Nature Reviews Urology. 2009;6(5):255-261. |
| PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community Urologists and Assay Performance in Reference Laboratory Setting. |
Shappell, SB et al.; Molecular Oncology Diagnostic Laboratory, Dallas, TX |
J Urol. 2009 Feb;73(2):363-8. |
| PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension (ECE) and Tumor Volume. |
Whitman, EJ et al.; Walter Reed Army Medical Center, Washington, DC |
J Urol. 2008(180), 1975-1979. |
| Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice. |
Marks, LS et al.; Geffen School of Medicine at UCLA, Los Angeles, CA |
Rev Urol. 2008, 10(3), 175-181 |
| Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3. |
Ankerst, DP et al.; University of Texas Health Sciences Center, San Antonio, TX |
J Urol. 2008, 180(4), 1303-1308. |
| Clinical utility of prostate carcinoma molecular diagnostic tests. |
Shappell, SB; Mosaic Diagnostics, Dallas, TX |
Rev Urol. 2008, 10(1), 44-69. |
| Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy. |
Haese, A. et al.; University Clinic Hamburg, Germany |
Eur Urol. 2008(54), 1081-1088. |
| Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results. |
van Gils, MP et al.; Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands |
Prostate. 2008, 68(11), 1215-22. |
| PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. |
Nakanishi, H.; The University of Texas M. D. Anderson Cancer Center, Houston, TX. |
J Urol. 2008, 179, 1804-9. |
| PCA3: A molecular urine assay for predicting prostate biopsy outcome
|
Deras, IL et al.; Gen-Probe, Inc., San Diego, CA
|
J Urol. 2008, 179(4), 1587-92. |
| Newer potential biomarkers in prostate cancer. |
Wright, JL et al.; University of Washington School of Medicine, Seattle, WA |
Rev Urol. 2007, 9(4), 207-13. |
| A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy. |
Sokoll, LJ, et al.; Johns Hopkins Medical Institutions, Baltimore, MD |
Clin Chim Acta. 2008, 389(1-2), 1-6. |
| PROGENSA® PCA3 test for prostate cancer detection. |
de la Taille, A. ; Henri Mondor Hospital, Créteil, France |
Expert Rev Mol Diagn. 2007, 7(5), 491-7. |
| Molecular PCA3 diagnostics on prostatic fluid. |
van Gils, MP et al.; Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands |
Prostate. 2007, 67(8), 881-7. |
| PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. |
Marks, LS et al.; Urological Sciences Research Foundation, Los Angeles, CA |
Urology. 2007, 69(3), 532-5. |
| Molecular markers for prostate cancer. |
Reynolds, MA et al.; Gen-Probe Incorporated, San Diego, CA |
Cancer Lett. 2007, 249(1), 5-13. |
| APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. |
Groskopf, J et al.; Gen-Probe Incorporated, San Diego, CA |
Clin Chem. 2006, 52(6), 1089-95. |
| Gene Fusions |
| Title |
Primary
Author and Affiliation |
Poster
- Where & When Presented |
| Molecular tests for the detection of prostate tumor derived nucleic acids in peripheral blood |
Jost, M., Day, J., Slaughter, R., Groskopf, J., Rittenhouse, H., Koreckij, T., Gonzales, D., Kinnunen, M., Vessella, R., & Reynolds, M.; Gen-Probe
Incorporated, San Diego, CA |
Poster 2009 AACR Annual Meeting in Denver, CO |
| TMPRSS2:ERG Gene Fusion Molecular Urine Test Correlates with Indicators of Prostate Cancer Aggressiveness |
Groskopf, J., Siddiqui, J., Sefton-Miller, L., Aubin, S. M., Blase, A., Varambally, S., Sakamoto, K., Fradet, Y., Schalken, J., Rittenhouse, H., & Chinnaiyan, A.; Gen-Probe
Incorporated, San Diego, CA |
Poster 2009 - Presented at Tuscon Symposium |
| TMPRSS2:ERG Gene Fusion Molecular Urine Test Correlates with Indicators of Prostate Cancer Aggressiveness |
Audin, S. M., Williamsen, S., Hodge, P., Meinke, J., Siddiqui, J., Sefton-Miller, L., Silberstein, J., Christensen, K., Blase, A., Kashefi, C., Fradet, Y., Rittenhouse, H., Sakamoto, K., Chinnaiyan, A., & Groskopf, J.; Gen-Probe Incorproated, San Diego, CA |
Poster 2009 American Urological Association in Chicago, IL |
*ASR (Analyte
Specific Reagent): Analytical and performance characteristics are
not established.
|
|
